Stock Quote
PXSL.OQ
More News
| Press Releases
| Key Developments
Profile
Pharmaxis Ltd is a specialty pharmaceutical company focused on the development of new products for the diagnosis and treatment of chronic respiratory and immune disorders. The Company has developed Aridol, as a tool for the diagnosis and management of asthma and chronic obstructive pulmonary disease... Full Description
Company Address
Pharmaxis Limited
Unit 2
10 Rodborough Road
Frenchs Forest NSW 2086
P: +612.94547200
F: +612.94513622
Unit 2
10 Rodborough Road
Frenchs Forest NSW 2086
P: +612.94547200
F: +612.94513622
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Novartis AG | CHF55.15 | +1.20 |
| AstraZeneca plc | £2,732.00 | +37.00 |
| Gilead Sciences, Inc. | $46.67 | +0.28 |
| PXSL.OQ | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 943.99 | 0.57 |
| ROI(TTM) | -- | 1.86 |
| ROE(TTM) | -- | 2.51 |
No consensus estimates data available.
| Total Revenue | $0.13M |
| Net Income | $-10.02M |
| EPS | $-0.75 |
